Literature DB >> 2159530

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.

Y Z Cao1, A E Friedman-Kien, Y X Huang, X L Li, M Mirabile, T Moudgil, D Zucker-Franklin, D D Ho.   

Abstract

Five hepatoma cell lines, including CZHC/8571, PLC/PRF/5, Hep3B, HepG2, and HUH7, were inoculated with three diverse isolates of human immunodeficiency virus type 1 (HIV-1). Productive infection was noted in all hepatoma cell lines, and expression of viral p24 antigen lasted for over 3 months, but its level decreased in proportion to the number of viable cells. HIV-1 antigens were also found in the cells by immunohistochemical staining and radioimmunoprecipitation assay, as were viral RNA by in situ hybridization and HIV-1-like particles by electron microscopy. Virus yield assays were also positive on supernatant fluids collected from hepatoma cultures inoculated with HIV-1. Despite their susceptibility to infection, all five hepatoma cell lines were negative for CD4 by immunofluorescence and for CD4 mRNA by slot-blot hybridization. In addition, HIV-1 infection of hepatoma cell lines was not blocked by anti-CD4 monoclonal antibody or soluble CD4. Together, these findings clearly demonstrate that all five hepatoma cell lines were susceptible to productive infection by HIV-1 in vitro via a CD4-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159530      PMCID: PMC249431          DOI: 10.1128/JVI.64.6.2553-2559.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Authors:  J M Harouse; C Kunsch; H T Hartle; M A Laughlin; J A Hoxie; B Wigdahl; F Gonzalez-Scarano
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

2.  Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow.

Authors:  T M Folks; S W Kessler; J M Orenstein; J S Justement; E S Jaffe; A S Fauci
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

3.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

4.  Hepatitis B virus X gene can transactivate heterologous viral sequences.

Authors:  J S Twu; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

Authors:  P R Clapham; J N Weber; D Whitby; K McIntosh; A G Dalgleish; P J Maddon; K C Deen; R W Sweet; R A Weiss
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.

Authors:  E Seto; T S Yen; B M Peterlin; J H Ou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1.

Authors:  X L Li; T Moudgil; H V Vinters; D D Ho
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA.

Authors:  D Zucker-Franklin; Y Z Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more
  35 in total

1.  Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.

Authors:  David M Iser; Nadia Warner; Peter A Revill; Ajantha Solomon; Fiona Wightman; Suha Saleh; Megan Crane; Paul U Cameron; Scott Bowden; Tin Nguyen; Cândida F Pereira; Paul V Desmond; Stephen A Locarnini; Sharon R Lewin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

2.  Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes.

Authors:  Stephanie M Zamule; Stephen C Strom; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2008-04-08       Impact factor: 5.192

3.  CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Authors:  N Thieblemont; N Haeffner-Cavaillon; A Ledur; J L'Age-Stehr; H W Ziegler-Heitbrock; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

4.  Ovine aortic smooth muscle cells allow the replication of visna-maedi virus in vitro.

Authors:  C Leroux; G Cordier; I Mercier; J Chastang; M Lyon; G Quérat; T Greenland; R Vigne; J F Mornex
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85.

Authors:  C Bova-Hill; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.

Authors:  Bill G Kapogiannis; Erin Leister; George K Siberry; Russell B Van Dyke; Bret Rudy; Patricia Flynn; Paige L Williams
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

Review 7.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

8.  The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.

Authors:  L Duan; I Ozaki; J W Oakes; J P Taylor; K Khalili; R J Pomerantz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells.

Authors:  O Scheglovitova; M R Capobianchi; G Antonelli; D Guanmu; F Dianzani
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.